B cell depletion in autoimmune rheumatic diseases

被引：21
|
作者：
Pitashny, M
Shoenfeld, Y
机构：
[1] Chaim Sheba Med Ctr, Dept Internal Med B, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Incumbent Laura Schwarz Kipp Chair Res Autoimmune, IL-69978 Tel Aviv, Israel
来源：
AUTOIMMUNITY REVIEWS | 2005年 / 4卷 / 07期
关键词：
anti-CD20; rituximab; autoimmune diseases; B cell depletion;
D O I：
10.1016/j.autrev.2005.03.002
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Rituximab is a chimeric mouse-human monoclonal antibody, which binds to CD20, a B cell surface marker, leading to cell death by complement induced lysis and apoptosis. Since the introduction of this drug in the treatment of non-Hodgkin lymphoma, its applications have been extended to autoimmune diseases. This review summarizes the actual possible uses of this novel immune system targeted drug, and explains the mechanism of B cell depletion in autoimmune diseases. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码：436 / 441
页数：6
相关论文
共 50 条
  • [21] B cell depletion in autoimmune disease
    Gorman, C
    Leandro, M
    Isenberg, D
    [J]. ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 4) : S17 - S21
  • [22] Methylation of T and B Lymphocytes in Autoimmune Rheumatic Diseases
    Deng, Tiantian
    Wang, Zihan
    Geng, Qishun
    Wang, Zhaoran
    Jiao, Yi
    Diao, Wenya
    Xu, Jiahe
    Deng, Tingting
    Luo, Jing
    Tao, Qingwen
    Xiao, Cheng
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2024, 66 (03) : 401 - 422
  • [23] B cell depletion in autoimmune disease
    Claire Gorman
    Maria Leandro
    David Isenberg
    [J]. Arthritis Res Ther, 5
  • [24] Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
    Engel, Pablo
    Gomez-Puerta, Jose A.
    Ramos-Casals, Manuel
    Lozano, Francisco
    Bosch, Xavier
    [J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (01) : 127 - 156
  • [25] Autoimmune Rheumatic Diseases
    Anaya, Juan-Manuel
    Shoenfeld, Yehuda
    Buttgereit, Frank
    Gonzalez-Gay, Miguel A.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [26] B cell depletion therapy in rheumatic disease
    Edwards, J. C. W.
    Cambridge, G.
    Leandro, M. J.
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (05): : 915 - 928
  • [27] B CELLS DEPLETION FOR THE TREATMENT OF SYSTEMIC AUTOIMMUNE DISEASES
    Velloso Feijoo, M. L.
    Rodriguez Montero, S.
    Plaza Aulestia, N.
    Marenco de la Fuente, J. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1210 - 1211
  • [28] Alterations In Circulating T Follicular Helper Cells and T Regulatory Cells In Autoimmune Rheumatic Diseases Treated With B Cell Depletion Therapy: Rituximab
    Lutalo, Pamela M. K.
    Zhao, Yuan
    Choong, Lee Meng
    Sangle, Shirish
    Spencer, Jo
    D'Cruz, David P.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S697 - S698
  • [29] TREG-cell therapies for autoimmune rheumatic diseases
    Makoto Miyara
    Yoshinaga Ito
    Shimon Sakaguchi
    [J]. Nature Reviews Rheumatology, 2014, 10 : 543 - 551
  • [30] TREG-cell therapies for autoimmune rheumatic diseases
    Miyara, Makoto
    Ito, Yoshinaga
    Sakaguchi, Shimon
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (09) : 543 - 551
12345